ALS Society of Alberta
Ice Bucket Challenge Funds New Clinical Trial
We are proud to announce funding for a new clinical trial from your donations through the ALS Ice Bucket Challenge and ALS Canada's partnership with Brain Canada and the Government of Canada!
The Arthur J. Hudson Translational Team Grant was first announced on May 3, 2014 at the ALS Canada Research Forum and the inaugural competition deadline was July 1, 2014. This new grant program is designed to fund teams of Canadian researchers to accelerate the movement of ideas out of the laboratory and into the clinic with the hope of assisting development of new therapeutics for ALS. It is the cornerstone of our ALS Canada Research Program designed to emphasize bench-to-bedside translation. For the first time ever, ALS Canada, in partnership with Brain Canada, have utilized an International Peer Review Panel consisting of seven European and American ALS experts, spanning the basic to clinical spectrum, who convened in Toronto in November to determine the top project amongst strong competition.
It is a great pleasure to announce that the recipient of the first Arthur J. Hudson Translational Team Grant is a team led by Dr. Lawrence Korngut, MD at the University of Calgary and also includes Dr. Lorne Zinman, MD from Sunnybrook Health Sciences Centre and University of Toronto. Together, they will pursue “A randomized controlled trial of pimozide in subjects with ALS”; a Phase II study involving 100 participants across 8 ALS clinics across Canada.
This trial, led by the Principal Investigator of the Canadian Neuromuscular Disease Registry (CNDR) and the Chair of the Canadian ALS Research Network (CALS) will examine whether pimozide, a drug already approved by Health Canada for use in psychoses like schizophrenia and Tourette’s syndrome, might slow progression of ALS. Pimozide is particularly effective at stabilizing neuromuscular function, which means it can strengthen the connection where the motor neuron meets the muscle (called the neuromuscular junction or NMJ). It is hoped that by strengthening this connection, there will be preservation of transmission of signals from the brain to the muscle and slowing of paralysis in ALS.
The ALS Society of Alberta is delighted to announce a wonderful new partnership! Mikael Backlund of the Calgary Flames has chosen the ALS Society of Alberta as one of his charities of choice!
ALS Societies across Canada announce the fund allocation from the Ice Bucket Challenge
The ALS Society of Alberta is excited to announce that the ALS Ice Bucket Challenge has raised $16.2 million in Canada due to the generosity of more than 260,000 Canadians. This record-breaking success has allowed for ALS to become a commonly known disease, and has given hope to the ALS community. Funds will be allocated toward the national ALS research program, and to client support services within each province.
ALS Societies will invest $10 million in ALS research and $6 million in programs that deliver critical support to Canadians living with ALS.
#IceBucketChallenge for ALS
Thank you to everyone who has participated in the #IceBucketChallenge!
We are overwhelmed at the amount of awareness and fundraising support we have received!